Methotrexate, Vincristine, Pegylated L-Asparaginase and Dexamethasone (MOAD) in Acute Lymphoblastic Leukemia (ALL) Salvage

NCT00905034 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Lymphocytic, Acute

Interventions

DRUG: Methotrexate
DRUG: Vincristine
DRUG: PEG-l-asparaginase
DRUG: Dexamethasone
DRUG: Rituximab

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]